BioPacificVentures concentrates on making selective investments in a small number of companies that are exceptionally innovative, have a sound business model and possess an experienced management team. Portfolio companies are actively supported by BioPacificVentures at all development stages, from R&D and clinical trial design to product launch and international expansion. Portfolio companies are uniquely positioned to leverage the deep commercial experience and strong network of industry relationships of the BioPacificVentures partners in the global nutrition, pharmaceutical, cosmetics, food and biotech areas.

BioPacificVentures has strong international networks and an internationally experienced management team, the result of a collaboration between leading New Zealand venture capital firm Direct Capital, international life sciences venture capital manager, inventages and one of the leading world’s leading agricultural research companies, AgResearch.

Direct Capital is a venture capital and private equity manager established in 1994. Today Direct Capital remains owned by three of its founding directors, Ross George, Mark Hutton and Bill Kermode.

To date Direct Capital has successfully raised 7 Funds with total capital available over the past 10 years for investment of more than NZ$440 million. BioPacificVentures is Direct Capital’s sixth fund.

inventages is a leading global venture capital manager with more than €1 billion under management in life sciences, with a focus on prevention, nutrition and wellness.

With offices in Nassau, Geneva and Auckland, inventages invests worldwide in equity from seed stage to private equity. Inventages has direct access to top management of global pharma and food companies, and also advises on merger, acquisition, and licensing deals. The inventages principals have outstanding investment, merger and acquisition, and industry track records.

AgResearch, New Zealand’s largest Crown Research Institute has 670 scientists (more than 40 per cent with PhDs), 20 associated companies, more than 30 collaborations with other international life science groups, and excellent access to a wide range of commercialisation opportunities based on New Zealand and Australian scientific research.

Combining the technical and commercialisation skills of inventages and AgResearch with the established local venture capital skills of Direct Capital is a first in the fledgling life science venture capital market in the Australasian region.